Alza Concerta Climbs To 15% Of ADHD Market With 170,000 Patients
Executive Summary
Alza Concerta holds 15% of the attention deficit hyperactive disorder market, Senior VP-Sales & Marketing Dan Swisher told the company's annual analyst meeting in New York City Feb. 27.